Lin, Rongjia
Chen, Wen
Zhu, Leilei
Pan, Xiaojie
Article History
Received: 31 October 2021
Accepted: 19 April 2022
First Online: 23 April 2022
Declarations
:
: This longitudinal study conformed to the provisions of the Declaration of Helsinki and was approved by the Chinese Clinical Trial Registry (Clinicaltrials.gov number: ChiCTR1900023419; approval date: May 20, 2019) and Chinese Ethics Committee of Registering Clinical Trials (approval no. from the ethics committee: ChiECRCT20190084). The primary sponsor is West China Hospital, Sichuan University, and the secondary sponsor is Fujian Provincial Hospital. All participants provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.